Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

ClinicalTrials.gov ID: NCT04705597

Public ClinicalTrials.gov record NCT04705597. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of BGE-175 in Hospitalized Adults With COVID-19

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objectives of this study are to evaluate the safety, tolerability, and efficacy of BGE-175 in participants ≥ 50 years of age hospitalized with documented COVID-19.

Study identification

NCT ID
NCT04705597
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
BioAge Labs, Inc.
Industry
Enrollment
194 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 18, 2021 (Actual)
Primary completion
Apr 20, 2022 (Actual)
Completion
May 19, 2022 (Actual)
Last update posted
Jul 3, 2023

2021 – 2022

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
11
Facility City State ZIP Site status
Banner Health Mesa Arizona 85202 —
Velocity Clinical Research, Chula Vista Chula Vista California 91911 —
Long Beach Medical Center Long Beach California 90806 —
UCI Center for Clinical Research Orange California 92868 —
Sharp Memorial Hospital San Diego California 92123 —
North Colorado Medical Center Greeley Colorado 80631 —
Stamford Hospital Stamford Connecticut 06904 —
University of Florida - Health, Jacksonville Jacksonville Florida 32209 —
Baptist Health, Lexington Lexington Kentucky 40503 —
University of Maryland Medical System Baltimore Maryland 21201 —
Jadestone Clinical Research, LLC Silver Spring Maryland 20904 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04705597, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 3, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04705597 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →